Enhanced adenovirus transduction of hMSCs using 3D hydrogel cell carriers

Molecular Biotechnology

Volumn 53, Issue 2, 2013, Pages 207-216

  Neumann, Alexander J ^a,b   Schroeder, Josh ^c   Alini, Mauro ^a   Archer, Charles W ^b   Stoddart, Martin J ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Adenovirus; Agarose; Alginate; Fibrin; Gene therapy; Gene transfer; Hydrogel; Mesenchymal stem cell

Indexed keywords

ADENOVIRAL VECTORS; ADENOVIRUS; AGAROSE; BIOACTIVE FACTOR; CELL CARRIER; CLINICAL APPLICATION; FIBRIN; HIGHER EFFICIENCY; HUMAN MESENCHYMAL STEM CELLS; MESENCHYMAL STEM CELL; OPERATING THEATRE; TRANSGENE;

ALGINATE; BACTERIOPHAGES; CELL CULTURE; GENE THERAPY; GENE TRANSFER; STEM CELLS; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE ENGINEERING;

HYDROGELS;

ADENOVIRUS VECTOR; AGAROSE; ALGINIC ACID; BONE MORPHOGENETIC PROTEIN 2; FIBRIN; IGF 1 PROTEIN; SOMATOMEDIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ARTICLE; CELL ENCAPSULATION; CONTROLLED STUDY; GENE THERAPY; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; NONHUMAN; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

AGED; ALGINATES; BONE MORPHOGENETIC PROTEIN 2; CELL CULTURE TECHNIQUES; CELLS, CULTURED; FEMALE; FIBRIN; GENETIC THERAPY; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; HYDROGELS; INSULIN-LIKE GROWTH FACTOR I; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; SEPHAROSE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSDUCTION, GENETIC; TRANSFECTION;

ADENOVIRIDAE;

EID: 84871649910     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-012-9522-y     Document Type: Article

References (60)

1. Langer, R.; Vacanti, J. P. (1993). Tissue engineering. Science, 260, 920-926. (Pubitemid 23209960)
2. Zuk, P. A.; Zhu, M.; Ashjian, P.; De Ugarte, D. A.; Huang, J. I.; Mizuno, H.; et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13, 4279-4295. (Pubitemid 35471185)
3. Cao, B.; Zheng, B.; Jankowski, R. J.; Kimura, S.; Ikezawa, M.; Deasy, B.; et al. (2003). Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nature Cell Biology, 5, 640-646. (Pubitemid 36818086)
4. De Bari, C.; Dell'Accio, F.; Tylzanowski, P.; Luyten, F. P. (2001). Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism, 44, 1928-1942. (Pubitemid 32758241)
5. Friedenstein, A. J.; Gorskaja, J. F.; Kulagina, N. N. (1976). Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Experimental Hematology, 4, 267-274.
6. Ashton, B. A.; Allen, T. D.; Howlett, C. R.; Eaglesom, C. C.; Hattori, A.; Owen, M. (1980). Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clinical Orthopaedics and Related Research 151, 294-307.
7. Johnstone, B.; Hering, T. M.; Caplan, A. I.; Goldberg, V. M.; Yoo, J. U. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research, 238, 265-272. (Pubitemid 28366150)
8. Urist, M. R. (1965). Bone: Formation by autoinduction. Science, 150, 893-899.
9. Gooch, K. J.; Blunk, T.; Courter, D. L.; Sieminski, A. L.; Vunjak-Novakovic, G.; Freed, L. E. (2002). Bone morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage. Tissue Engineering, 8, 591-601. (Pubitemid 34857796)
10. Sekiya, I.; Larson, B. L.; Vuoristo, J. T.; Reger, R. L.; Prockop, D. J. (2005). Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell and Tissue Research, 320, 269-276. (Pubitemid 40684753)
11. Sellers, R. S.; Zhang, R.; Glasson, S. S.; Kim, H. D.; Peluso, D.; D'Augusta, D. A.; et al. (2000). Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal of Bone and Joint Surgery, 82, 151-160. (Pubitemid 30097015)
12. Uusitalo, H.; Hiltunen, A.; Ahonen, M.; Kahari, V. M.; Aro, H.; Vuorio, E. (2001). Induction of periosteal callus formation by bone morphogenetic protein-2 employing adenovirus-mediated gene delivery. Matrix Biology, 20, 123-127. (Pubitemid 32396762)
13. Virk, M. S.; Conduah, A.; Park, S. H.; Liu, N.; Sugiyama, O.; Cuomo, A.; et al. (2008). Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone, 42, 921-931.
14. Gelse, K.; von der, M. K.; Aigner, T.; Park, J.; Schneider, H. (2003). Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis and Rheumatism, 48, 430-441. (Pubitemid 36278012)
15. Palmer, G. D.; Steinert, A.; Pascher, A.; Gouze, E.; Gouze, J. N.; Betz, O.; et al. (2005). Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Molecular Therapy, 12, 219-228. (Pubitemid 41025091)
16. Steinert, A. F.; Palmer, G. D.; Pilapil, C.; Noth, U.; Evans, C. H.; Ghivizzani, S. C. (2009). Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Engineering Part A, 15, 1127-1139.
17. Steinert, A.; Weber, M.; Dimmler, A.; Julius, C.; Schutze, N.; Noth, U.; et al. (2003). Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate. Journal of Orthopaedic Research, 21, 1090-1097. (Pubitemid 37322390)
18. Weisser, J.; Rahfoth, B.; Timmermann, A.; Aigner, T.; Brauer, R.; von der, M. K. (2001). Role of growth factors in rabbit articular cartilage repair by chondrocytes in agarose. Osteoarthritis Cartilage, 9(Suppl A), S48-S54.
19. Ahmed, T. A.; Dare, E. V.; Hincke, M. (2008). Fibrin: A versatile scaffold for tissue engineering applications. Tissue Engineering Part B Reviews, 14, 199-215. (Pubitemid 351839214)
20. Pelaez, D.; Huang, C. Y.; Cheung, H. S. (2009). Cyclic compression maintains viability and induces chondrogenesis of human mesenchymal stem cells in fibrin gel scaffolds. Stem Cells and Development, 18, 93-102.
21. Eyrich, D.; Wiese, H.; Maier, G.; Skodacek, D.; Appel, B.; Sarhan, H.; et al. (2007). In vitro and in vivo cartilage engineering using a combination of chondrocyte-seeded long-term stable fibrin gels and polycaprolactone-based polyurethane scaffolds. Tissue Engineering, 13, 2207-2218. (Pubitemid 47404436)
22. Grad, S.; Kupcsik, L.; Gorna, K.; Gogolewski, S.; Alini, M. (2003). The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: Potential and limitations. Biomaterials, 24, 5163-5171. (Pubitemid 37279148)
23. Li, Z.; Kupcsik, L.; Yao, S. J.; Alini, M.; Stoddart, M. J. (2009). Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Engineering Part A, 15, 1729-1737.
24. Visna, P.; Pasa, L.; Cizmar, I.; Hart, R.; Hoch, J. (2004). Treatment of deep cartilage defects of the knee using autologous chondrograft transplantation and by abrasive techniques-a randomized controlled study. Acta Chirurgica Belgica, 104, 709-714. (Pubitemid 40115687)
25. Gouze, E.; Pawliuk, R.; Pilapil, C.; Gouze, J. N.; Fleet, C.; Palmer, G. D.; et al. (2002). In vivo gene delivery to synovium by lentiviral vectors. Molecular Therapy, 5, 397-404. (Pubitemid 34308664)
26. Nita, I.; Ghivizzani, S. C.; Galea-Lauri, J.; Bandara, G.; Georgescu, H. I.; Robbins, P. D.; et al. (1996). Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis and Rheumatism, 39, 820-828. (Pubitemid 26140428)
27. Roessler, B. J.; Allen, E. D.; Wilson, J. M.; Hartman, J. W.; Davidson, B. L. (1993). Adenoviral-mediated gene transfer to rabbit synovium in vivo. Journal of Clinical Investigation, 92, 1085-1092. (Pubitemid 23262434)
28. Kang, R.; Marui, T.; Ghivizzani, S. C.; Nita, I. M.; Georgescu, H. I.; Suh, J. K.; et al. (1997). Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: A feasibility study. Osteoarthritis Cartilage, 5, 139-143. (Pubitemid 27141777)
29. Mason, J. M.; Grande, D. A.; Barcia, M.; Grant, R.; Pergolizzi, R. G.; Breitbart, A. S. (1998). Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: Potential utility in gene therapy for osteochondral repair. Gene Therapy, 5, 1098-1104. (Pubitemid 28401312)
30. Dinser, R.; Kreppel, F.; Zaucke, F.; Blank, C.; Paulsson, M.; Kochanek, S.; et al. (2001). Comparison of long-term transgene expression after non-viral and adenoviral gene transfer into primary articular chondrocytes. Histochemistry and Cell Biology, 116, 69-77. (Pubitemid 32695820)
31. Steinert, A. F.; Noth, U.; Tuan, R. S. (2008). Concepts in gene therapy for cartilage repair. Injury, 39(Suppl 1), S97-S113. (Pubitemid 351296061)
32. Thomas, C. E.; Ehrhardt, A.; Kay, M. A. (2003). Progress and problems with the use of viral vectors for gene therapy. Nature Reviews Genetics, 4, 346-358. (Pubitemid 36538359)
33. Hao, J.; Yao, Y.; Varshney, R. R.; Wang, L.; Prakash, C.; Li, H.; et al. (2008). Gene transfer and living release of transforming growth factor-beta3 for cartilage tissue engineering applications. Tissue Engineering Part C Methods, 14, 273-280.
34. Meinel, L.; Hofmann, S.; Betz, O.; Fajardo, R.; Merkle, H. P.; Langer, R.; et al. (2006). Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: Comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials, 27, 4993-5002. (Pubitemid 43866922)
35. Steinert, A. F.; Proffen, B.; Kunz, M.; Hendrich, C.; Ghivizzani, S. C.; Noth, U.; et al. (2009). Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Research and Therapy, 11, R148.
36. Danthinne, X.; Imperiale, M. J. (2000). Production of first generation adenovirus vectors: A review. Gene Therapy, 7, 1707-1714.
37. Peng, Z. (2005). Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers. Human Gene Therapy, 16, 1016-1027. (Pubitemid 41324561)
38. Penny, W. F.; Hammond, H. K. (2004). Clinical use of intracoronary gene transfer of fibroblast growth factor for coronary artery disease. Current Gene Therapy, 4, 225-230. (Pubitemid 38842624)
39. Gelse, K.; Jiang, Q. J.; Aigner, T.; Ritter, T.; Wagner, K.; Poschl, E.; von der, M. K.; and Schneider, H. (2001). Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis and Rheumatism, 44, 1943-1953. (Pubitemid 32758242)
40. Zachos, T.; Diggs, A.; Weisbrode, S.; Bartlett, J.; Bertone, A. (2007). Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. Molecular Therapy, 15, 1543-1550. (Pubitemid 47099312)
41. Ho, S. T.; Cool, S. M.; Hui, J. H.; Hutmacher, D. W. (2010). The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials, 31, 38-47.
42. Huang, C. Y.; Reuben, P. M.; D'Ippolito, G.; Schiller, P. C.; Cheung, H. S. (2004). Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. The Anatomical Record Part A Discoveries in Molecular, Cellular, and Evolutionary Biology, 278, 428-436. (Pubitemid 38619654)
43. Li, Z.; Yao, S. J.; Alini, M.; Stoddart, M. J. (2009). Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Engineering Part A 16(2), 575-584.
44. He, T. C.; Zhou, S.; da Costa, L. T.; Yu, J.; Kinzler, K. W.; Vogelstein, B. (1998). A simplified system for generating recombinant adenoviruses. Proceedings of the National Academy of Sciences of USA, 95, 2509-2514. (Pubitemid 28145972)
45. Kupcsik, L.; Stoddart, M. J.; Li, Z.; Benneker, L. M.; Alini, M. (2010). Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Engineering Part A, 16, 1845-1855.
46. Kupcsik, L.; Alini, M.; Stoddart, M. J. (2009). Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Engineering Part A, 15, 2309-2313.
47. Schek, R. M.; Hollister, S. J.; Krebsbach, P. H. (2004). Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Molecular Therapy, 9, 130-138. (Pubitemid 38208336)
48. Teraishi, F.; Umeoka, T.; Saito, T.; Tsukagoshi, T.; Tanaka, N.; Fujiwara, T. (2003). A novel method for gene delivery and expression in esophageal epithelium with fibrin glues containing replication-deficient adenovirus vector. Surgical Endoscopy, 17, 1845-1848. (Pubitemid 37553829)
49. Breen, A.; Dockery, P.; O'Brien, T.; Pandit, A. (2009). Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery. Journal of Biomedical Materials Research Part A, 89, 876-884.
50. Breen, A. M.; Dockery, P.; O'Brien, T.; Pandit, A. S. (2008). The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. Biomaterials, 29, 3143-3151.
51. Olmsted-Davis, E. A.; Gugala, Z.; Gannon, F. H.; Yotnda, P.; McAlhany, R. E.; Lindsey, R. W.; et al. (2002). Use of a chimeric adenovirus vector enhances BMP2 production and bone formation. Human Gene Therapy, 13, 1337-1347. (Pubitemid 35034513)
52. Shayakhmetov, D. M.; Papayannopoulou, T.; Stamatoyannopoulos, G.; Lieber, A. (2000). Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. Journal of Virology, 74, 2567-2583. (Pubitemid 30117566)
53. Majumdar, M. K.; Wang, E.; Morris, E. A. (2001). BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. Journal of Cellular Physiology, 189, 275-284. (Pubitemid 33063295)
54. Sailor, L. Z.; Hewick, R. M.; Morris, E. A. (1996). Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. Journal of Orthopaedic Research, 14, 937-945. (Pubitemid 27044463)
55. Toh, W. S.; Yang, Z.; Liu, H.; Heng, B. C.; Lee, E. H.; Cao, T. (2007). Effects of culture conditions and bone morphogenetic protein 2 on extent of chondrogenesis from human embryonic stem cells. Stem Cells, 25, 950-960. (Pubitemid 46572592)
56. Morral, N.; O'Neal, W. K.; Rice, K.; Leland, M. M.; Piedra, P. A.; Aguilar-Cordova, E.; et al. (2002). Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Human Gene Therapy, 13, 143-154. (Pubitemid 34075178)
57. Thomas, C. E.; Birkett, D.; Anozie, I.; Castro, M. G.; Lowenstein, P. R. (2001). Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain. Molecular Therapy, 3, 36-46. (Pubitemid 32509803)
58. Pascher, A.; Palmer, G. D.; Steinert, A.; Oligino, T.; Gouze, E.; Gouze, J. N.; et al. (2004). Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Therapy, 11, 133-141. (Pubitemid 38159685)
59. He, C. X.; Li, N.; Hu, Y. L.; Zhu, X. M.; Li, H. J.; Han, M.; et al. (2011). Effective gene delivery to mesenchymal stem cells based on the reverse transfection and three-dimensional cell culture system. Pharmaceutical Research, 28, 1577-1590.
60. Aviles, M. O.; Shea, L. D. (2011). Hydrogels to modulate lentivirus delivery in vivo from microporous tissue engineering scaffolds. Drug Delivery and Translational Research, 1, 91-101.